The FastFit® Podcast
The side effects people associate with GLPs are overwhelmingly tied to dosing too aggressively. Semaglutide (GLP only) is what she calls “inelegant and clunky.” Tirzepatide (GLP + GIP) is more complete, better tolerated, and effective at lower doses. Retatrutide (GLP + GIP + glucagon) is coming later this year for patients who are metabolically inflexible and resistant to tirzepatide.
66 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The FastFit® Podcast!